EVA1A and metabolic dysfunction-associated steatotic liver disease: Consistent with these reports, our study demonstrated that CD36 ablation reverses the enhanced fatty acid uptake and lipid accumulation brought on due to EVA1A deficiency, highlighting CD36-dependent fatty acid uptake as the central mechanism in EVA1A deficiency-induced MASLD pathogenesis.